Considering the resistance of SPY1 to GPX4 inhibitor RSL3 in NSC34 and different tumor cells, we believe that SPY1 and downstream pathways may be effective protectors against ferroptosis caused by GPX4 deletion. Here, GPX4 is linked to neoplasm.